Unicep
Silgan Unicep is a Spokane, Washington-based contract manufacturer specializing in blow-fill-seal unit-dose filling and packaging of liquid, gel, and cream formulations for pharmaceutical, diagnostics, animal health, oral healthcare, and consumer healthcare customers, operating FDA-registered and ISO 13485-certified facilities.
- Company typePrivate
- Founded1991
- HeadquartersSpokane, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Unicep does
Silgan Unicep, founded in 1991 and headquartered at 4122 S Grove Rd, Spokane, Washington, is a contract manufacturer specializing in unit-dose packaging of liquid, gel, and cream formulations for pharmaceutical, healthcare, diagnostics, animal health, and consumer products companies. The company operates from FDA-registered and ISO 13485:2016-certified cGMP-compliant facilities, providing compounding/mixing, custom fill, and secondary packaging and kitting services to customers that engage via a consultative, project-based sales motion.
The company's core platform is blow-fill-seal (BFS) manufacturing technology, deployed across a portfolio of proprietary unit-dose configurations: Twist-Tip™ (twist-off tip for precise dispensing), MicroDose® (small-volume precision dosing), PreciseDose™ (accurate measurement and delivery), SwabDose™ (diagnostic swab applications), HLX™ (specialized unit-dose), and Standard BFS for conventional applications. Complementary service offerings include tube filling, syringe filling, form-fill-seal pouch, custom unit-dose packaging, and end-to-end program management from R&D through commercialization.
Revenue is generated exclusively through project-based B2B contract manufacturing engagements, with quote-based pricing tied to formula complexity, fill volumes, regulatory requirements, and production runs, typically structured as multi-year contracts. Silgan Unicep operates as a wholly-owned subsidiary of Silgan Dispensing, part of Silgan Holdings Inc. (NASDAQ: SLGN), and currently serves customers across North America with the option of global market access through the parent's broader packaging and dispensing portfolio.
Unicep firmographics
Firmographics- Name
- Unicep
- Legal name
- Silgan Unicep
- Website
- https://unicep.com
- Company type
- Private
- Founded year
- 1991
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Silgan Unicep is a Spokane, Washington-based contract manufacturer specializing in blow-fill-seal unit-dose filling and packaging of liquid, gel, and cream formulations for pharmaceutical, diagnostics, animal health, oral healthcare, and consumer healthcare customers, operating FDA-registered and ISO 13485-certified facilities.
- Ownership category
- akta.pro rank
Where Unicep is headquartered
LocationHeadquarters
- HQ city
- Spokane
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Unicep business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Contract Manufacturing Services: Full-service contract manufacturing for liquid, gel, and cream unit-dose products. Revenue generated through project-based contracts for mixing, filling, and packaging services. Customers define scope from new product launch to existing product transfer. Includes compounding/mixing, custom fill solutions, program management, and secondary packaging services.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based contract manufacturing pricing |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Unicep product offering
Product offeringCore offering
Silgan Unicep is a contract manufacturer specializing in liquid, gel, and cream unit-dose filling and packaging using proprietary blow-fill-seal (BFS) technologies such as Twist-Tip™, MicroDose®, PreciseDose™, HLX™, SwabDose™, and standard BFS, along with tube filling, syringe filling, form-fill-seal pouches, and custom unit-dose packaging. Services span compounding/mixing, R&D, custom fill solutions, program management, quality, and secondary packaging and kitting for pharmaceutical, diagnostics, animal health, oral healthcare, and consumer healthcare customers.
Product overview
Silgan Unicep is a premier liquid, gel, and cream contract manufacturer specializing in the mold and fill of unit-dose solutions. The company offers a portfolio of proprietary blow-fill-seal technologies including Twist-Tip™, MicroDose®, PreciseDose™, HLX™, and Standard Blow-Fill-Seal solutions, complemented by SwabDose™, Tube Filling, Syringe Filling, Form Fill Seal Pouch, and Custom Unit-Dose Packaging services. Supporting these packaging products are contract manufacturing services including Compounding/Mixing, Quality Services, Research & Development, Custom Fill Solutions, Program Management, and Secondary Packaging and Kits. The company operates FDA-registered and ISO 13485:2016-certified facilities serving Diagnostics & Imaging, Animal Health, Oral Healthcare, and Consumer Healthcare markets.
Differentiator
Problem solved
Functional benefit
Brands
- Twist-Tip™: Proprietary Blow-Fill-Seal Unit-Dose packaging solution
- MicroDose®
- PreciseDose™
- HLX™
- SwabDose™
- MicroDose
Products and services
- Twist-Tip™ Proprietary Blow-Fill-Seal Unit-Dose
Quantifiable outcome
- Over 30 years of proven expertise since 1991
Companies that use Unicep
Customer profileSegments4 records
Ideal customer profiles4 records
Unicep technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Unicep partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Silgan DispensingcoreSilgan Unicep is a company of Silgan Dispensing, part of Silgan Holdings Inc. (NASDAQ: SLGN). This corporate parent relationship provides operational backing, manufacturing expertise, and integration within the broader Silgan packaging and dispensing solutions portfolio. Silgan Holdings is a leading manufacturer of consumer goods packaging and dispensing solutions.
Scale indicators3 records
Recent moves4 records
Expansion highlights4 records
Unicep competitors and assessment
Company assessmentOthers
- West Pharmaceutical Services: Global manufacturer of pharmaceutical elastomer components, seals, and drug delivery systems for injectable and sterile packaging. Adjacent to Unicep's unit-dose and syringe-filling business as a key component supplier and complementary packaging partner in the same pharmaceutical value chain.
Direct peers
- Unither Pharmaceuticals: French-headquartered BFS pharmaceutical contract manufacturer producing sterile single-dose liquid and gel formats for ophthalmic, respiratory, and topical applications. Most direct competitor to Unicep given matching BFS technology, unit-dose focus, and pharma/healthcare customer base.
- Rommelag: German manufacturer of BFS machinery and a contract manufacturer operating its own BFS lines for aseptic liquid packaging. Closely comparable in that it offers the same BFS technology stack as Unicep to pharma and healthcare customers.
- Weiler Engineering: U.S.-based manufacturer of aseptic filling equipment (ASEP-TECH) and provider of aseptic contract manufacturing services for liquids. Comparable in sterile/aseptic liquid filling capabilities and customer overlap in pharma and consumer healthcare.
Broad incumbents
- Becton Dickinson (BD): Major medical device and life sciences company with extensive unit-dose and prefillable syringe/syringe-fill capabilities. Comparable to Unicep in unit-dose delivery formats, diagnostics, and pharmaceutical packaging components, though at much larger scale and with device-level scope.
- Catalent: Large global CDMO offering softgel, oral, injectable, and aseptic fill-finish services across hundreds of dosage forms. Competes with Unicep in aseptic liquid fill-finish but at vastly greater scale and with a broader service portfolio.
- Thermo Fisher Scientific (Patheon): Global pharma services platform that includes Patheon CDMO operations spanning small-molecule, biologic, sterile fill-finish, and oral solid dose. Competes with Unicep in aseptic liquid/sterile packaging for pharma with significantly larger scale and integrated drug substance services.
- Recipharm: European-headquartered CDMO providing contract development and manufacturing for oral, sterile, topical, and inhalation products. Overlaps with Unicep in sterile liquid and topical fill-finish for pharmaceutical customers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights7 records
Customer concentration
Unicep social profiles
Digital presenceUnicep compliance and trust
Trust signalCompliance3 records
Unicep financial estimates
Financial estimateRevenue estimate
Valuation estimate
Unicep leadership team
Management profileNumber of profiles
Profiles1 record
Unicep funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Unicep M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Unicep
What does Unicep do?
Silgan Unicep is a contract manufacturer specializing in liquid, gel, and cream unit-dose filling and packaging using proprietary blow-fill-seal (BFS) technologies such as Twist-Tip™, MicroDose®, PreciseDose™, HLX™, SwabDose™, and standard BFS, along with tube filling, syringe filling, form-fill-seal pouches, and custom unit-dose packaging. Services span compounding/mixing, R&D, custom fill solutions, program management, quality, and secondary packaging and kitting for pharmaceutical, diagnostics, animal health, oral healthcare, and consumer healthcare customers.
Is Unicep a public or private company?
Unicep is a private company. It is classified as corporate owned and is currently operating.
When was Unicep founded?
Unicep was founded in 1991. It employs 251 to 500 people.
Where is Unicep based?
Unicep is headquartered in Spokane, United States, in the North America region.
How does Unicep make money?
One revenue line is on record: contract Manufacturing Services.
Who are Unicep's main competitors?
West Pharmaceutical Services is listed as an others. Direct peers are Unither Pharmaceuticals, Rommelag and Weiler Engineering. Broad incumbents are Becton Dickinson (BD), Catalent, Thermo Fisher Scientific (Patheon) and Recipharm.
Does Unicep have an API?
No public API is recorded for Unicep.